example, certain activated amide systems based on Kenner’s
safety-catch sulfonamides,6a-c acylureas,6d and pyroglutamyl
imides6e have been developed. Other systems utilize NfS
acyl transfer to produce thioesters,9,10 which in a way are
mechanistically reminiscent of protein splicing.11 Most of
these systems require acidic conditions to catalyze amide-
to-thioester conversion which is followed by transthioesteri-
fication with a free thiol compound to generate a thioester.
Aimoto’s group reported the use of an autoactivating
C-terminal Cys-Pro ester (CPE) to mediate amide-to-thioester
conversion at neutral or slightly basic pH, which is driven
by diketopiperazine formation to trap the transiently exposed
R-amine of Cys through intramolecular aminolysis of the
prolyl ester.10a Despite an inconvenience in loading the first
amino acid to the CPE linker and the need for a relatively
reactive glycolic ester at the C-terminus, this method is
appealing for its clever design.
catalyst for thioesterification.11 NR-Cys alkylation (e.g.,
methylation and ethylation) would increase the ratio of the
productive cis form to the nonproductive trans form in the
resultant tertiary amide bond, but the conversion of the trans
isomer to the cis isomer would still need to overcome a
significant energy barrier no less than in the case of a normal
secondary amide peptide bond.12 For example, even an Xaa-
Pro tertiary amide has a high rotational barrier (∆G‡ )
18-21.5 kcal/mol) and a low cis/trans ratio of ∼0.05/1.0 in
unstructured polypeptide chains.12 For this reason, the
N-alkyl Cys systems, which require acidic conditions for
thioesterification, are usually very inefficient and give very
low yields of thioester products.9d,3b
These considerations have led us to propose a new NfS acyl
transfer system to generate thioesters for NCL, as shown in
Scheme 2. This system is based on the use of a peptide
In our efforts to develop new and convenient methods for
peptide thioester synthesis, we have paid particular attention
to the NfS acyl transfer reaction. Mechanistically, in order
for the NfS acyl transfer to take place, the planar amide
bond must be in the conformation where the thiol-bearing
N-substituent is anti to the carbonyl oxygen, as shown in
Scheme 1 for an Xaa-Cys peptide bond. This requires an
Scheme 2. N-to-S Acyl Transfer Using an
N,N-Bis(2-mercaptoethyl)-Substituted Tertiary Amide To
Generate a Thioester Peptide for NCL
Scheme 1
.
Mechanism of NfS Acyl Transfer Involving a
C-terminal tertiary amide 1, namely N,N-bis(2-mercaptoethyl)-
amide or BMEA. With this system, the NfS acyl transfer
reaction is twice as likely. It also obviates the need for trans-cis
amide isomerization prior to the NfS acyl transfer reaction
step because, with two ꢀ-mercaptoethyl (HS-Et) N-substitutions,
the BMEA amide will always have one HS group correctly
positioned for the intramolecular thiolysis reaction (Scheme 2),
and the relatively high basicity of the secondary amine in the
thioesterification product 2 would also make its trapping easier
via protonation, which might help drive the formation of 2 at
an NCL-operable pH. Coupling thioesterification with native
chemical ligation would then ultimately lead the overall reaction
in its forward direction (Scheme 2).
Peptidyl-Cys Amide Bond
energetically unfavorable cis isomer of the secondary amide,
a conformation it almost never adopts. And trans-cis
isomerization of a secondary amide peptide bond requires a
significant amount of activation energy (∆H‡ ∼20 kcal/
mol).12 Furthermore, to drive the reaction equilibrium toward
thioester formation, there must be a trapping mechanism,
e.g., protonation, for the newly exposed amine. In protein
splicing, trans-cis amide isomerization is catalyzed presum-
ably by the intein which also serves as a general acid-base
For the synthesis of a C-terminal BMEA peptide 1 shown
in Scheme 2, we designed a bis(2-mercaptoethyl)amine-
derived trityl resin 5 which was prepared in straightforward
reaction steps (Scheme 3). Thus, (2-aminoethyl)sulfanyl-trityl
(9) (a) Kawakami, T.; Sumida, M.; Nakamura, K.; Vorherr, T.; Aimoto,
S. Tetrahedron Lett. 2005, 46, 8805. (b) Ollivier, N.; Behr, J.-B.; El-Mahdi,
O.; Blanpain, A.; Melnyk, O. Org. Lett. 2005, 7, 2647. (c) Nagaike, F.;
Onuma, Y.; Kanazawa, C.; Hojo, H.; Ueki, A.; Nakahara, Y.; Nakahara,
Y. Org. Lett. 2006, 8, 4465. (d) Hojo, H.; Onuma, Y.; Akimoto, Y.;
Nakahara, Y.; Nakahara, Y. Tetrahedron Lett. 2007, 48, 25. (e) Ohta, Y.;
Itoh, S.; Shigenaga, A.; Shintaku, S.; Fujii, N.; Otaka, A. Org. Lett. 2006,
8, 467. (f) Tsuda, S.; Shigenaga, A.; Bando, K.; Otaka, A. Org. Lett. 2009,
Scheme 3. Synthesis of C-Terminal BMEA Peptides
11, 823
.
(10) (a) Kawakami, T.; Aimoto, S. Tetrahedron Lett. 2007, 48, 1903.
(b) Kang, J.; Reynolds, N. L.; Tyrrell, C.; Dorin, J. R.; Macmillan, D. Org.
Biomol. Chem. 2009, 7, 4918
.
(11) (a) Chong, S.; Mersha, F. B.; Comb, D. G.; Scott, M. E.; Landry,
D.; Vence, L. M.; Perler, F. B.; Benner, J.; Kucera, R. B.; Hirvonen, C. A.;
Pelletier, J. J.; Paulus, H.; Xu, M.-Q. Gene 1997, 192, 271. (b) Evans, T. C.;
Xu, M. Q. Chem. ReV. 2002, 102, 4869. (c) Muir, T. W. Annu. ReV.
Biochem. 2003, 72, 249.
(12) (a) Kessler, H. Angew. Chem., Int. Ed. 1970, 9, 219–235. (b)
Schiene-Fischer, C.; Fischer, G. J. Am. Chem. Soc. 2001, 123, 6227–6231.
Org. Lett., Vol. 13, No. 3, 2011
387